Relying on the relationship with known disease-causing variants in homologous proteins to predict pathogenicity ofSORL1variants in Alzheimer’s disease
preprint
OA: closed
Abstract
ABSTRACT SORL1 encodes the retromer-associated receptor SORLA that functions in endosomal recycling. Rare variants in SORL1 have been associated with Alzheimer’s disease (AD) and rare pathogenic variants are estimated to occur in up to 2.75% of early onset AD patients and in 1.5% of unrelated late onset AD patients. While truncation mutations are observed almost exclusively in AD patients, it is currently unknown which among the hundreds of rare missense variants identified in SORL1 , are pathogenic. Here we address this question by relying on SORLA’s distinct molecular architecture. First, we completed a structure-guided sequence alignment for all the protein domains. Next, we identified proteins that contain domains homologous to those of SORLA, which include pathogenic variants for monogenic diseases. We identified the analogous domain positions of these variants in the SORLA protein sequence and showed that variants in these positions similarly impair SORL1 , and lead to AD. Together, our findings represent a comprehensive compendium on SORLA protein variation and functional effects, which allowed us to prioritize SORL1 genetic variants into high or moderate priority mutations. We envision that this compendium will be used by clinical geneticists for assessing variants they identify in patients, allowing further development of diagnostic procedures and patient counseling strategies. Utimately, this compendium will inform investigations into the molecular mechanisms of endosomal recycling which will support the development of therapeutic treatment strategies for SORL1 variant-carrying patients.
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (1)
References (56)
- Endosomal trafficking is required for glycosylation and normal maturation of the Alzheimer’s-associated protein sorLA via crossref
- doi:10.1002/humu.20725 via crossref
- doi:10.1016/j.neurobiolaging.2007.10.013 via crossref
- doi:10.1016/j.neulet.2009.06.014 via crossref
- doi:10.1038/ng.2802 via crossref
- doi:10.1038/s41588-018-0311-9 via crossref
- doi:10.1038/s41588-021-00921-z via crossref
- doi:10.1038/s41588-022-01024-z via crossref
- doi:10.1007/s00401-016-1566-9 via crossref
- doi:10.1038/ejhg.2017.87 via crossref
- doi:10.1002/acn3.582 via crossref
- doi:10.1038/s41588-022-01208-7 via crossref
- doi:10.1038/s41586-020-2308-7 via crossref
- doi:10.1016/j.jalz.2016.01.012 via crossref
- doi:10.1007/s00401-019-01991-4 via crossref
- doi:10.1002/ana.20667 via crossref
- doi:10.1523/jneurosci.2272-11.2012 via crossref
- doi:10.1038/s41586-018-0526-z via crossref
- doi:10.1073/pnas.2212180120 via crossref
- doi:10.1016/j.celrep.2021.110182 via crossref
- doi:10.1007/s00018-022-04182-9 via crossref
- doi:10.1186/s13073-022-01070-6 via crossref
- doi:10.1074/jbc.271.49.31379 via crossref
- doi:10.14800/rci.1611 via crossref
- doi:10.1038/nsmb.2954 via crossref
- doi:10.1038/88556 via crossref
- doi:10.1093/bioinformatics/btq447 via crossref
- doi:10.1074/jbc.m100857200 via crossref
- doi:10.1186/1472-6807-9-46 via crossref
- doi:10.1006/jmbi.1998.2115 via crossref
- doi:10.1186/s40478-017-0441-9 via crossref
- doi:10.1002/alz.073476 via crossref
- doi:10.1021/bi00040a017 via crossref
- doi:10.1016/0014-5793(95)00939-7 via crossref
- doi:10.3233/jad-180415 via crossref
- doi:10.1016/j.radcr.2020.10.030 via crossref
- doi:10.1016/s0140-6736(97)08083-5 via crossref
- doi:10.1038/nsb0996-758 via crossref
- doi:10.1038/41798 via crossref
- doi:10.1021/bi0015156 via crossref
- doi:10.1172/jci114531 via crossref
- doi:10.1016/j.atherosclerosis.2013.12.028 via crossref
- doi:10.1038/mp.2015.121 via crossref
- doi:10.1016/j.neurobiolaging.2017.07.001 via crossref
- doi:10.3233/jad-190193 via crossref
- doi:10.1021/ja00007a056 via crossref
- doi:10.1016/j.str.2003.11.024 via crossref
- doi:10.1016/0959-440x(92)90233-w via crossref
- doi:10.1006/jmbi.1999.3360 via crossref
- doi:10.1002/pro.5560031104 via crossref
- doi:10.1093/protein/15.12.1015 via crossref
- doi:10.1042/bj20051364 via crossref
- doi:10.1016/j.neuron.2019.07.010 via crossref
- doi:10.1016/j.celrep.2020.107719 via crossref
- doi:10.1038/ng1943 via crossref
- doi:10.1002/alz.12638 via crossref
Source provenance
- crossref
- last seen: 2026-05-27T01:00:07.243295+00:00
- europepmc
- last seen: 2026-05-19T01:45:01.086888+00:00
- unpaywall
- last seen: 2026-08-07T06:39:35.550527+00:00